The rapid onset of headache, chills, nausea, and myalgia within hours after vaccination in this study suggests the vaccine formulation activated innate responses, but the higher severity of reactions after the second vaccination suggests that tissue-resident antigen-specific effectors from the first vaccination may have also contributed to the exaggerated response.
Previous work from our laboratories has shown that polyanhydride nanoparticles of various formulations activate dendritic cells (DCs) in vitro [18].
At this time, we do not know the precise mechanisms responsible for this, but speculate that the oxykine formulation possibly activates the host immune system besides exerting direct SOD action.
In principle, this decrease in plant-available P was expected as the absence of a sink for available P in the soil system (such as plant roots) leads to an increase in plant-available P in soil solution that, in turn, may cause a feedback inhibition of those processes and enzyme activities involved in the P mobilization mechanisms activated by these formulations [22].
These results represent the proof of concept that well-designed plant virus carriers of epitopes produced in plant can reasonably be used into peptide vaccine formulations aimed to activate cell-mediated immune responses.
This review article presents a broad overview about the fundamental concepts of drug releasing nanoplatforms activated by AMF, their formulations, and their efficiency in vitro and in vivo.
Incorporation of 10 mol% PEG and anti-E-selectin antibody in these formulations resulted in selective siRNA delivery into activated endothelial cells.
Since NF- κB pathway is neither activated (important in cases of active infections) nor modulated/suppressed, the formulation appears not to harm immune function.
An isotherm equation for water adsorption in microporous carbons was derived from the basic formulation of the Do model, originally developed for activated carbons.
B cells were activated with CD40L-Tri or other CD40L formulations (shrt-CD40L, NIH3T3/tCD40L, Ultra-CD40L), irradiated, and co-cultured at a ratio of 2 1 or 10 1 with allogeneic CD4+ or CD8+ T cells.
